Literature DB >> 24900762

Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening.

Dmitry I Osolodkin1, Liubov I Kozlovskaya2, Evgenia V Dueva1, Victor V Dotsenko3, Yulia V Rogova2, Konstantin A Frolov3, Sergey G Krivokolysko3, Ekaterina G Romanova4, Alexey S Morozov4, Galina G Karganova5, Vladimir A Palyulin6, Vladimir M Pentkovski7, Nikolay S Zefirov6.   

Abstract

Flaviviruses form a large family of enveloped viruses affecting millions of people over the world. To date, no specific therapy was suggested for the infected people, making the treatment exclusively symptomatic. Several attempts were performed earlier for the design of fusion inhibitors for mosquito-borne flaviviruses, whereas for the tick-borne flaviviruses such design had not been performed. We have constructed homology models of envelope glycoproteins of tick-transmitted flaviviruses with the detergent binding pocket in the open state. Molecular docking of substituted 1,4-dihydropyridines and pyrido[2,1-b][1,3,5]thiadiazines was made against these models, and 89 hits were selected for the in vitro experimental evaluation. Seventeen compounds showed significant inhibition against tick-borne encephalitis virus, Powassan virus, or Omsk hemorrhagic fever virus in the 50% plaque reduction test in PEK cells. These compounds identified through rational design are the first ones possessing reproduction inhibition activity against tick-borne flaviviruses.

Entities:  

Keywords:  1,4-dihydropyridines; Antiviral compounds; flavivirus; pyrido[2,1-b][1,3,5]thiadiazines

Year:  2013        PMID: 24900762      PMCID: PMC4027560          DOI: 10.1021/ml400226s

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

Review 1.  Neuroinvasive flavivirus infections.

Authors:  Gregorius J Sips; Jan Wilschut; Jolanda M Smit
Journal:  Rev Med Virol       Date:  2011-11-16       Impact factor: 6.989

2.  Identification of novel target sites and an inhibitor of the dengue virus E protein.

Authors:  Ragothaman Yennamalli; Naidu Subbarao; Thorsten Kampmann; Ross P McGeary; Paul R Young; Bostjan Kobe
Journal:  J Comput Aided Mol Des       Date:  2009-02-25       Impact factor: 3.686

Review 3.  The medicinal chemistry of dengue fever.

Authors:  Andrew J Stevens; Michelle E Gahan; Suresh Mahalingam; Paul A Keller
Journal:  J Med Chem       Date:  2009-12-24       Impact factor: 7.446

Review 4.  [Efficiency of use of immunoglobulin preparations for the postexposure prevention of tick-borne encephalitis in Russia (a review of semi-centennial experience)].

Authors:  N A Pen'evskaia; N V Rudakov
Journal:  Med Parazitol (Mosk)       Date:  2010 Jan-Mar

5.  The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.

Authors:  F A Rey; F X Heinz; C Mandl; C Kunz; S C Harrison
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

Review 6.  Flaviviruses and flavivirus vaccines.

Authors:  Franz X Heinz; Karin Stiasny
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

7.  An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.

Authors:  Tine De Burghgraeve; Suzanne J F Kaptein; Nilda V Ayala-Nunez; Juan A Mondotte; Boris Pastorino; Svetlana S Printsevskaya; Xavier de Lamballerie; Michael Jacobs; Maria Preobrazhenskaya; Andrea V Gamarnik; Jolanda M Smit; Johan Neyts
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 8.  Flavivirus cell entry and membrane fusion.

Authors:  Jolanda M Smit; Bastiaan Moesker; Izabela Rodenhuis-Zybert; Jan Wilschut
Journal:  Viruses       Date:  2011-02-22       Impact factor: 5.818

Review 9.  Targeting cell entry of enveloped viruses as an antiviral strategy.

Authors:  Elodie Teissier; François Penin; Eve-Isabelle Pécheur
Journal:  Molecules       Date:  2010-12-30       Impact factor: 4.411

10.  Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors.

Authors:  Jinn-Moon Yang; Yan-Fu Chen; Yu-Yin Tu; Kuei-Rong Yen; Yun-Liang Yang
Journal:  PLoS One       Date:  2007-05-09       Impact factor: 3.240

View more
  6 in total

1.  Nucleoside inhibitors of tick-borne encephalitis virus.

Authors:  Luděk Eyer; James J Valdés; Victor A Gil; Radim Nencka; Hubert Hřebabecký; Michal Šála; Jiří Salát; Jiří Černý; Martin Palus; Erik De Clercq; Daniel Růžek
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

Review 2.  The Use of Ex Vivo Organ Cultures in Tick-Borne Virus Research.

Authors:  Jeffrey M Grabowski; Danielle K Offerdahl; Marshall E Bloom
Journal:  ACS Infect Dis       Date:  2018-02-23       Impact factor: 5.084

Review 3.  A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.

Authors:  Jeffrey M Grabowski; Catherine A Hill
Journal:  Front Cell Infect Microbiol       Date:  2017-12-22       Impact factor: 5.293

4.  Enhanced taxonomy annotation of antiviral activity data from ChEMBL.

Authors:  Anastasia A Nikitina; Alexey A Orlov; Liubov I Kozlovskaya; Vladimir A Palyulin; Dmitry I Osolodkin
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

5.  Spectrum of antiviral activity of 4-aminopyrimidine N-oxides against a broad panel of tick-borne encephalitis virus strains.

Authors:  Evgenia V Dueva; Ksenia K Tuchynskaya; Liubov I Kozlovskaya; Dmitry I Osolodkin; Kseniya N Sedenkova; Elena B Averina; Vladimir A Palyulin; Galina G Karganova
Journal:  Antivir Chem Chemother       Date:  2020 Jan-Dec

6.  Anti-Tick-Borne Encephalitis Virus Activity of Novel Uridine Glycoconjugates Containing Amide or/and 1,2,3-Triazole Moiety in the Linker Structure.

Authors:  Gabriela Brzuska; Gabriela Pastuch-Gawolek; Monika Krawczyk; Boguslaw Szewczyk; Ewelina Krol
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.